⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3101885 | 0.82 | — | — | |
| SCHEMBL195172 | 0.80 | — | — | |
| SCHEMBL6053208 | 0.72 | — | — | |
| SCHEMBL280044 | 0.71 | — | — | |
| SCHEMBL20183688 | 0.71 | — | — | |
| SCHEMBL1870088 | 0.63 | — | — | |
| SCHEMBL1422550 | 0.61 | — | — | |
| SCHEMBL3102511 | 0.59 | — | — | |
| SCHEMBL4303564 | 0.59 | — | — | |
| SCHEMBL6233840 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426447-B2 | Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2013-04-23 | — | — | US | claimed |
| US-20090324580-A1 | Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases | CENIX BIOSCIENCE GMBH (DE) | 2009-12-31 | — | — | US | claimed |
| US-20090181966-A1 | PGD2 receptor antagonists for the treatment of inflammatory diseases | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-07-16 | — | — | US | claimed |
| EP-1740547-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-01-10 | — | — | EP | claimed |
| US-20050256158-A1 | PGD2 receptor antagonists for the treatment of inflammatory diseases | MILLENNIUM PHARMACEUTICALS, INC. | 2005-11-17 | — | — | US | claimed |
| WO-2005100321-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-10-27 | — | — | WO | claimed |
| EP-0643329-B2 | Radiation curable liquid composition, particularly for stereolithography | VANTICO AG (CH) | 2002-02-06 | — | — | EP | claimed |
| EP-0643329-B1 | Radiation curable liquid composition, particularly for stereolithography | CIBA GEIGY AG (CH) | 1998-12-23 | — | — | EP | claimed |
| US-5629133-A | POLYETHERSILOXANE BLOCK COPOLYMER | CIBA-GEIGY CORPORATION (US) | 1997-05-13 | — | — | US | claimed |
| US-5573889-A | Process for adjusting the sensitivity to radiation of photopolymerizable compositions | CIBA-GEIGY CORPORATION (US) | 1996-11-12 | — | — | US | claimed |
| EP-0378144-A2 | Photocurable compositions | CIBA-GEIGY AG (CH) | 1990-07-18 | — | — | EP | claimed |
| EP-0369212-A1 | Derivatives of (hetero)aryloxynaphthalene, process, and (hetero)aryloxynaphthyl amines, and their use as herbicides | BAYER AG (DE) | 1990-05-23 | — | — | EP | claimed |
| EP-0347679-A1 | 1,7-Dioxynaphthalene derivatives | BAYER AG (DE) | 1989-12-27 | — | — | EP | claimed |
| EP-0342440-A1 | Halogen-substituted phenoxybenzyl-(thi)ol derivatives | BAYER AG (DE) | 1989-11-23 | — | — | EP | claimed |
| EP-0338306-A2 | Halogen-substituted phenoxybenzyl compounds | BAYER AG (DE) | 1989-10-25 | — | — | EP | claimed |
| EP-0315008-A2 | Derivatives of (6-(hetero)aryloxy-naphthalin-2-yl-oxy)alcanoic acid | BAYER AG (DE) | 1989-05-10 | — | — | EP | claimed |
| EP-0313908-A2 | Halogen-substituted phenoxyphenylpropionic acid derivatives | BAYER AG (DE) | 1989-05-03 | — | — | EP | claimed |
| EP-0309864-A1 | Alpha-(5-aryloxy-naphthalen-1-yl-oxy)-propionic-acid derivatives | BAYER AG (DE) | 1989-04-05 | — | — | EP | claimed |
| EP-0272533-A2 | Substituted phenoxypyridines | BAYER AG (DE) | 1988-06-29 | — | — | EP | claimed |
| EP-0154816-A2 | Azo compounds containing sulfonic-acid groups | BASF Aktiengesellschaft (DE) | 1985-09-18 | — | — | EP | claimed |